Xenon Pharmaceuticals Reports 2017 Financial Results and Provides Corporate Update Pharmaceutical Investing
Acer Therapeutics Reports Fourth Quarter and Full-Year 2017 Financial Results and Provides Corporate Update Pharmaceutical Investing
Collegium Reports Fourth Quarter Financial Results and Provides Corporate Update Pharmaceutical Investing
BriaCell Announces Proposed Investment by Leading Biotech Funds and Concurrent Non-Brokered Financing for aggregate gross proceeds of up to $4.8 Million Biotech Investing
Aptose Biosciences Announces Exclusive License Agreement for Dual BET/Kinase Targeting Program With OHM Oncology Biotech Investing
Tetraphase Pharmaceuticals Reports Fourth Quarter and Full-Year 2017 Financial Results Pharmaceutical Investing
InMed Provides Update on BayMedica Operations and Strengthens Focus on Pharmaceutical Development Pipeline
